SCHEMBL7067066

SCHEMBL7067066

CCCC(C(N)=O)C(CC(C)C)C(=O)N1CCN(CCO)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.37
POLB P06746 1/20 0.37
MMP1 P03956 4/20 0.37
MMP2 P08253 4/20 0.37
MMP8 P22894 4/20 0.37
MMP3 P08254 3/20 0.37
HRH2 P25021 4/20 0.36
HRH1 P35367 4/20 0.36
CYP2C19 P33261 1/20 0.34
NOTCH1 P46531 1/20 0.33
PSEN1 P49768 1/20 0.33
PSEN2 P49810 1/20 0.33
RBPJ Q06330 1/20 0.33
APH1B Q8WW43 1/20 0.33
NCSTN Q92542 1/20 0.33
APH1A Q96BI3 1/20 0.33
PSENEN Q9NZ42 1/20 0.33
HSD11B1 P28845 1/20 0.33
MMP9 P14780 1/20 0.32
MMP13 P45452 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7067070 1.00 ALDH1A1 (0.37) ALDH1A1POLBMMP1MMP2MMP8
SCHEMBL7069503 0.93 HRH2 (0.39) MMP1MMP2MMP8MMP3HRH2
SCHEMBL7069509 0.93 HRH2 (0.39) MMP1MMP2MMP8MMP3HRH2
SCHEMBL7067898 0.88 HRH2 (0.39) MMP1MMP2MMP8MMP3HRH2
SCHEMBL7067903 0.88 HRH2 (0.39) MMP1MMP2MMP8MMP3HRH2
SCHEMBL7067824 0.88 MMP1 (0.39) ALDH1A1MMP1MMP2MMP8MMP3
SCHEMBL7067823 0.88 MMP1 (0.39) ALDH1A1MMP1MMP2MMP8MMP3
SCHEMBL7080559 0.87 MMP1 (0.39) ALDH1A1MMP1MMP2MMP8MMP3
SCHEMBL7080558 0.87 MMP1 (0.39) ALDH1A1MMP1MMP2MMP8MMP3
SCHEMBL7069433 0.84 MMP1 (0.42) MMP1MMP2MMP8MMP3NOTCH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030232985-A1 Succinoylamino heterocycles as inhibitors of a beta protein production THOMPSON LORIN A (US) 2003-12-18 US disclosed
US-20030073701-A1 Succinoylamino heterocycles as inhibitors of a beta protein production BRISTOL-MYERS SQUIBB PHARMA COMPANY 2003-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030073701-A1 Succinoylamino heterocycles as inhibitors of a beta protein production APP, BACE1, APH1A ALDH1A1 3091/4885POLB 2847/4885MMP1 4360/4885
US-20030232985-A1 Succinoylamino heterocycles as inhibitors of a beta protein production APP, BACE1, APH1A ALDH1A1 3091/4885POLB 2847/4885MMP1 4360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.